Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phytocannabinoids—A Green Approach toward Non-Alcoholic Fatty Liver Disease Treatment
Klaudia Berk, Wiktor Bzdęga, Karolina Konstantynowicz-Nowicka, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 393-393
Open Access | Times Cited: 20

Showing 20 citing articles:

Cannabidiol and Cannabidiol Metabolites: Pharmacokinetics, Interaction with Food, and Influence on Liver Function
Kieran Shay Struebin Abbotts, Taylor Russell Ewell, Hannah Michelle Butterklee, et al.
Nutrients (2022) Vol. 14, Iss. 10, pp. 2152-2152
Open Access | Times Cited: 34
Novel Intravenous Nanoemulsions Based on Cannabidiol-Enriched Hemp Oil—Development and Validation of an HPLC-DAD Method for Cannabidiol Determination
Agnieszka Sobczak, Piotr M. Zieliński, Anna Jelińska, et al.
Molecules (2025) Vol. 30, Iss. 2, pp. 278-278
Open Access
Targeting the Endocannabinoidome: A Novel Approach to Managing Extraintestinal Complications in Inflammatory Bowel Disease
Dinesh Thapa, Anshu Ghimire, Leon N. Warne, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 478-478
Open Access
Could Alcohol Abuse and Dependence on Junk Foods Inducing Obesity and/or Illicit Drug Use Represent Danger to Liver in Young People with Altered Psychological/Relational Spheres or Emotional Problems?
Giovanni Tarantino, Mauro Cataldi, Vincenzo Citro
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10406-10406
Open Access | Times Cited: 19
Observed Impact of Long-Term Consumption of Oral Cannabidiol on Liver Function in Healthy Adults
Robert C. Kaufmann, Keith Aqua, Jeffrey Lombardo, et al.
Cannabis and Cannabinoid Research (2021) Vol. 8, Iss. 1, pp. 148-154
Open Access | Times Cited: 23
Cannabinoids and Chronic Liver Diseases
Ralph‐Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 16, pp. 9423-9423
Open Access | Times Cited: 18
Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)
Tangui Barré, Hélène Fontaine, Clémence Ramier, et al.
Clinical Nutrition (2022) Vol. 41, Iss. 3, pp. 610-619
Open Access | Times Cited: 15
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control
Taylor Russell Ewell, Kieran Shay Struebin Abbotts, Natasha Williams, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 817-817
Open Access | Times Cited: 15
The Endocannabinoid System and Physical Activity—A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders
Tomasz Charytoniuk, Hubert Żywno, Klaudia Berk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3083-3083
Open Access | Times Cited: 9
Distinct Effects of Cannabidiol on Sphingolipid Metabolism in Subcutaneous and Visceral Adipose Tissues Derived from High-Fat-Diet-Fed Male Wistar Rats
Klaudia Berk, Karolina Konstantynowicz-Nowicka, Tomasz Charytoniuk, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5382-5382
Open Access | Times Cited: 8
The Effects of Long-Term Self-Dosing of Cannabidiol on Drowsiness, Testosterone Levels, and Liver Function
Robert C. Kaufmann, Amber L. Harris Bozer, Amanda Kube, et al.
Medical Cannabis and Cannabinoids (2023) Vol. 6, Iss. 1, pp. 32-40
Open Access | Times Cited: 4
Decreasing the burden of non-alcoholic fatty liver disease: From therapeutic targets to drug discovery opportunities
Ricardo Amorim, Pedro Soares, Daniel Chavarria, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116723-116723
Open Access | Times Cited: 1
Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review
Lauren Eadie, Lindsay A. Lo, Michael Boivin, et al.
Journal of Gastroenterology and Hepatology (2024)
Open Access | Times Cited: 1
Effects of Full-Spectrum Cannabis Oil with a Cannabidiol:Tetrahydrocannabinol 2:1 Ratio on the Mechanisms Involved in Hepatic Steatosis and Oxidative Stress in Rats Fed a Sucrose-Rich Diet
Valentina Degrave, Michelle Berenice Vega Joubert, Paola I. Ingaramo, et al.
Medical Cannabis and Cannabinoids (2023) Vol. 6, Iss. 1, pp. 170-183
Open Access | Times Cited: 3
Comparative Pharmacokinetic Study of Rhubarb Anthraquinones in Normal and Nonalcoholic Fatty Liver Disease Rats
Fang Zhang, Rui Wu, Yanfang Liu, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2023) Vol. 49, Iss. 1, pp. 111-121
Closed Access | Times Cited: 3
Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock?
Tangui Barré, Vincenzo Di Marzo, Fabienne Marcellin, et al.
Cannabis and Cannabinoid Research (2022) Vol. 8, Iss. 1, pp. 5-11
Open Access | Times Cited: 4
Pharmacokinetic Investigation of Commercially Available Edible Marijuana Products in Humans: Potential Influence of Body Composition and Influence on Glucose Control
Taylor Russell Ewell, Kieran Shay Streubin Abbotts, Natasha Williams, et al.
(2021)
Open Access | Times Cited: 5
Effect of Cannabidiol and hemp extract on viability and function of hepatocytes derived from human induced pluripotent stem cells
Kayla Campasino, Miranda R. Yourick, Yang Zhao, et al.
Toxicology in Vitro (2024) Vol. 101, pp. 105933-105933
Open Access
Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
Tangui Barré, Fabrice Carrat, Clémence Ramier, et al.
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 1
Nonneurological aspects of the endocannabinoid system: Nonalcoholic fatty liver disease
Reem Ghazali, Vinood B. Patel
Elsevier eBooks (2023), pp. 507-518
Closed Access
Page 1

Scroll to top